ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 652,87
0,57%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kiniksa Pharmaceuticals International PLC (KNSA)

  7. Kiniksa Pharmaceuticals International PLC (KNSA) Actualités

KNSA

Kiniksa Pharmaceuticals (KNSA)

Kiniksa Pharmaceuticals International PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KNSA
DateHeureSourceTitreSymboleSociété
24/06/202414h00GlobeNewswire Inc.Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent PericarditisNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
17/06/202414h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis InitiativeNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
14/06/202422h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
04/06/202422h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
29/05/202423h19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
07/05/202422h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
23/04/202413h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
16/04/202422h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
02/04/202413h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Announces Development Indication for AbiprubartNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
05/03/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
01/03/202423h29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
28/02/202413h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
21/02/202422h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
14/02/202422h39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
04/01/202413h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Provides Corporate UpdateNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
02/01/202422h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
02/11/202321h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
31/10/202312h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
24/10/202322h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
10/08/202322h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
25/07/202313h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
17/07/202314h00GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
08/06/202323h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
07/06/202323h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
06/06/202322h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
04/05/202322h25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
02/05/202313h30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals International PLC
01/05/202322h01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
08/03/202320h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
02/03/202322h26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KNSAKiniksa Pharmaceuticals International PLC
 Showing the most relevant articles for your search:NASDAQ:KNSA

Dernières Valeurs Consultées

USOTC
CSTAF
Constellation Acquisitio... (QX)
BIT
F15691
Vontobel Financial Produ...
BIT
S29654
Societe Generale Effekten
USOTC
THMG
Thunder Mountain Gold (QB)
COIN
ONEPAYGBP
BIT
P21M05
NLBNPIT21M05 20240918 1800
BIT
F17466
Vontobel Financial Produ...
UNSW3
ORDIUSDT
Ordinals Chain
NYSE
VETZ
Tidal ETF Trust
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés